vs

Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and American Express (AXP). Click either name above to swap in a different company.

Autolus Therapeutics plc is the larger business by last-quarter revenue ($21.2M vs $18.9M, roughly 1.1× American Express). American Express runs the higher net margin — 15.7% vs -373.3%, a 389.0% gap on every dollar of revenue.

Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.

American Express Company, together with its subsidiaries, provides charge and credit payment card products, and travel-related services worldwide. The company operates through three segments: Global Consumer Services Group, Global Commercial Services, and Global Merchant and Network Services. Its products and services include payment and financing products; network services; accounts payable expense management products and services; and travel and lifestyle services. The company's products an...

AUTL vs AXP — Head-to-Head

Bigger by revenue
AUTL
AUTL
1.1× larger
AUTL
$21.2M
$18.9M
AXP
Higher net margin
AXP
AXP
389.0% more per $
AXP
15.7%
-373.3%
AUTL

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
AUTL
AUTL
AXP
AXP
Revenue
$21.2M
$18.9M
Net Profit
$-79.1M
$3.0M
Gross Margin
Operating Margin
-337.9%
Net Margin
-373.3%
15.7%
Revenue YoY
11.4%
Net Profit YoY
3.6%
15.0%
EPS (diluted)
$-0.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AUTL
AUTL
AXP
AXP
Q1 26
$18.9M
Q4 25
$10.9B
Q3 25
$21.2M
$10.4B
Q2 25
$20.9M
$10.3B
Q1 25
$9.0M
$9.6B
Q4 24
$10.0B
Q3 24
$0
$9.7B
Q2 24
$0
$9.8B
Net Profit
AUTL
AUTL
AXP
AXP
Q1 26
$3.0M
Q4 25
$2.5B
Q3 25
$-79.1M
$2.9B
Q2 25
$-47.9M
$2.9B
Q1 25
$-70.2M
$2.6B
Q4 24
$2.2B
Q3 24
$-82.1M
$2.5B
Q2 24
$-58.3M
$3.0B
Operating Margin
AUTL
AUTL
AXP
AXP
Q1 26
Q4 25
28.2%
Q3 25
-337.9%
36.7%
Q2 25
-292.6%
34.4%
Q1 25
-726.3%
34.6%
Q4 24
27.7%
Q3 24
33.0%
Q2 24
38.6%
Net Margin
AUTL
AUTL
AXP
AXP
Q1 26
15.7%
Q4 25
22.5%
Q3 25
-373.3%
27.9%
Q2 25
-229.0%
28.0%
Q1 25
-781.1%
26.8%
Q4 24
21.8%
Q3 24
25.8%
Q2 24
30.7%
EPS (diluted)
AUTL
AUTL
AXP
AXP
Q1 26
Q4 25
$3.52
Q3 25
$-0.30
$4.14
Q2 25
$-0.18
$4.08
Q1 25
$-0.26
$3.64
Q4 24
$3.04
Q3 24
$-0.31
$3.49
Q2 24
$-0.22
$4.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AUTL
AUTL
AXP
AXP
Cash + ST InvestmentsLiquidity on hand
$86.1M
Total DebtLower is stronger
$60.4M
Stockholders' EquityBook value
$265.5M
$34.0M
Total Assets
$661.9M
$308.9M
Debt / EquityLower = less leverage
1.78×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AUTL
AUTL
AXP
AXP
Q1 26
Q4 25
$742.0M
Q3 25
$86.1M
$1.3B
Q2 25
$123.8M
$197.0M
Q1 25
$95.8M
$261.0M
Q4 24
$221.0M
Q3 24
$657.1M
$120.0M
Q2 24
$705.9M
$188.0M
Total Debt
AUTL
AUTL
AXP
AXP
Q1 26
$60.4M
Q4 25
$56.4B
Q3 25
$57.8B
Q2 25
$58.2B
Q1 25
$51.2B
Q4 24
$49.7B
Q3 24
$53.5B
Q2 24
$51.5B
Stockholders' Equity
AUTL
AUTL
AXP
AXP
Q1 26
$34.0M
Q4 25
$33.5B
Q3 25
$265.5M
$32.4B
Q2 25
$346.5M
$32.3B
Q1 25
$371.1M
$31.2B
Q4 24
$30.3B
Q3 24
$477.0M
$29.7B
Q2 24
$527.8M
$29.5B
Total Assets
AUTL
AUTL
AXP
AXP
Q1 26
$308.9M
Q4 25
$300.1B
Q3 25
$661.9M
$297.6B
Q2 25
$721.0M
$295.6B
Q1 25
$746.3M
$282.2B
Q4 24
$271.5B
Q3 24
$827.5M
$271.0B
Q2 24
$853.6M
$272.2B
Debt / Equity
AUTL
AUTL
AXP
AXP
Q1 26
1.78×
Q4 25
1.68×
Q3 25
1.78×
Q2 25
1.80×
Q1 25
1.64×
Q4 24
1.64×
Q3 24
1.80×
Q2 24
1.74×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AUTL
AUTL
AXP
AXP
Operating Cash FlowLast quarter
$-67.9M
Free Cash FlowOCF − Capex
$-72.3M
FCF MarginFCF / Revenue
-341.2%
Capex IntensityCapex / Revenue
20.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-322.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AUTL
AUTL
AXP
AXP
Q1 26
Q4 25
$3.1B
Q3 25
$-67.9M
$6.2B
Q2 25
$-72.8M
$4.4B
Q1 25
$-75.6M
$4.8B
Q4 24
$5.8B
Q3 24
$-76.7M
$-1.8B
Q2 24
$-51.1M
$4.5B
Free Cash Flow
AUTL
AUTL
AXP
AXP
Q1 26
Q4 25
$2.3B
Q3 25
$-72.3M
$5.6B
Q2 25
$-80.1M
$3.7B
Q1 25
$-83.8M
$4.3B
Q4 24
$5.3B
Q3 24
$-86.3M
$-2.3B
Q2 24
$-51.9M
$4.0B
FCF Margin
AUTL
AUTL
AXP
AXP
Q1 26
Q4 25
21.4%
Q3 25
-341.2%
53.6%
Q2 25
-382.6%
36.3%
Q1 25
-933.1%
45.0%
Q4 24
53.1%
Q3 24
-23.3%
Q2 24
40.4%
Capex Intensity
AUTL
AUTL
AXP
AXP
Q1 26
Q4 25
6.6%
Q3 25
20.8%
6.3%
Q2 25
34.8%
6.0%
Q1 25
91.8%
4.5%
Q4 24
5.0%
Q3 24
4.7%
Q2 24
5.8%
Cash Conversion
AUTL
AUTL
AXP
AXP
Q1 26
Q4 25
1.25×
Q3 25
2.15×
Q2 25
1.51×
Q1 25
1.84×
Q4 24
2.66×
Q3 24
-0.72×
Q2 24
1.50×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AUTL
AUTL

Segment breakdown not available.

AXP
AXP

Discount revenue$9.5M50%
Other$8.9M47%
Deposits with banks and other$512.0K3%

Related Comparisons